FDA.reportPublic FDA data

infliximab-abda 100 MG Injection [Renflexis]

RxCUI
1927290
RxNorm name
infliximab-abda 100 MG Injection [Renflexis]
Display name
infliximab-abda 100 MG Injection [Renflexis]
Full name
infliximab-abda 100 MG Injection [Renflexis]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761054Renflexisinfliximab-abda351(k) BiosimilarRx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3827e1be-f328-45f7-b113-311b57039f8cRENFLEXIS 100 MG Injection [PSN] · infliximab-abda 100 MG Injection [Renflexis] [SBD] · Renflexis 100 MG Injection [SY]314These highlights do not include all the information needed to use RENFLEXIS safely and effectively. See full prescribing information for RENFLEXIS. RENFLEXIS (infliximab-abda) for injection, for intravenous use Initial U.S. Approval: 2017 RENFLEXIS (infliximab-abda) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe20230126
dbf738c4-3fac-4422-a9d8-51d9c83a8789RENFLEXIS 100 MG Injection [PSN] · infliximab-abda 100 MG Injection [Renflexis] [SBD] · Renflexis 100 MG Injection [SY]36These highlights do not include all the information needed to use RENFLEXIS ® safely and effectively. See full prescribing information for RENFLEXIS. RENFLEXIS (infliximab-abda) for injection, for intravenous use Initial U.S. Approval: 2017 RENFLEXIS (infliximab-abda) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful diffe20251105